# Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers

> **NCT01499472** · NA · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 300 (estimated)

## Conditions studied

- Diabetic Foot

## Interventions

- **DEVICE:** shock wave therapy
- **DEVICE:** dermagold shockwave
- **PROCEDURE:** standard of care

## Key facts

- **NCT ID:** NCT01499472
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2015-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2011-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01499472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01499472, "Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01499472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*